ストックスクリーナーアプリを入手
1.19
2.46%
-0.03
アフターアワーズ：
1.1714
-0.0186
-1.56%
Allakos Inc (ALLK) 最新ニュース
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire Inc.
Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions
Zacks Investment Research
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
GlobeNewswire Inc.
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
GlobeNewswire Inc.
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
Zacks Investment Research
Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug
Zacks Investment Research
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
Benzinga
Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
Allakos Announces a Restructuring to Focus on Development of AK006
GlobeNewswire Inc.
Street Calls of the Week: Pepsi may fizzle out
Investing.com
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
Benzinga
Where Allakos Stands With Analysts
Benzinga
What 4 Analyst Ratings Have To Say About Allakos
Benzinga
1.06%
1.27%
大文字化:
|
ボリューム (24 時間):